ATC Group: M02AB01 Capsaicin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M02AB01 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M02 Topical products for joint and muscular pain
3 M02A Topical products for joint and muscular pain
4 M02AB Capsaicin and similar agents
5 M02AB01 Capsaicin

Active ingredients in M02AB01

Active Ingredient Description
Capsaicin

Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides.

Related product monographs

Title Information Source Document Type  
AXSAIN Cream Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZACIN Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Ireland (IE)

Malta (MT)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.